These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 25744524)
1. Attacking the system: Next-generation auto-immune therapies target pathways rather than symptoms. Hunter P EMBO Rep; 2015 Apr; 16(4):411-5. PubMed ID: 25744524 [No Abstract] [Full Text] [Related]
2. Targeting IL-10 in auto-immune diseases. Tian G; Li JL; Wang DG; Zhou D Cell Biochem Biophys; 2014 Sep; 70(1):37-49. PubMed ID: 24639111 [TBL] [Abstract][Full Text] [Related]
3. Two Cheers for Crohn's Disease and Periodontitis: Beta-Defensin-2 as an Actionable Target to Intervene on Two Clinically Distinct Diseases. Keskin M; Zeidán-Chuliá F; Gursoy M; Könönen E; Rautava J; Gursoy UK OMICS; 2015 Aug; 19(8):443-50. PubMed ID: 26171729 [TBL] [Abstract][Full Text] [Related]
6. Experimental drugs for treatment of autoimmune myocarditis. Han L; Guo S; Wang Y; Yang L; Liu S Chin Med J (Engl); 2014; 127(15):2850-9. PubMed ID: 25146626 [TBL] [Abstract][Full Text] [Related]
7. [Clinical studies in oncology--a challenge for clinical and academic pathology]. Röcken C Dtsch Med Wochenschr; 2013 May; 138(20):1073-6. PubMed ID: 23670265 [No Abstract] [Full Text] [Related]
8. Immunometabolism: an overview and therapeutic prospects in autoimmune diseases. Stathopoulou C; Nikoleri D; Bertsias G Immunotherapy; 2019 Jun; 11(9):813-829. PubMed ID: 31120393 [TBL] [Abstract][Full Text] [Related]
9. The Untapped Opportunity and Challenge of Immunometabolism: A New Paradigm for Drug Discovery. Mazumdar C; Driggers EM; Turka LA Cell Metab; 2020 Jan; 31(1):26-34. PubMed ID: 31839485 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of hepatitis C with new direct antiviral drugs: towards a disease cure]. Halfon P; Cacoub P Rev Med Interne; 2014 Apr; 35(4):219-21. PubMed ID: 24559772 [No Abstract] [Full Text] [Related]
12. Metabolic Checkpoints in Differentiation of Helper T Cells in Tissue Inflammation. Roy S; Rizvi ZA; Awasthi A Front Immunol; 2018; 9():3036. PubMed ID: 30692989 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor energy pathways for targeted esophagus cancer therapy. Shafaee A; Dastyar DZ; Islamian JP; Hatamian M Metabolism; 2015 Oct; 64(10):1193-8. PubMed ID: 26271140 [TBL] [Abstract][Full Text] [Related]
14. [Anti-platelets without a bleeding risk: novel targets and strategies]. Schaff M; Gachet C; Mangin PH Biol Aujourdhui; 2015; 209(3):211-28. PubMed ID: 26820829 [TBL] [Abstract][Full Text] [Related]
15. Precision medicine in the treatment of primary immunodeficiency diseases. Leiding JW; Ballow M Curr Opin Allergy Clin Immunol; 2018 Apr; 18(2):159-166. PubMed ID: 29406361 [TBL] [Abstract][Full Text] [Related]
16. Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways. Allman EL; Painter HJ; Samra J; Carrasquilla M; Llinás M Antimicrob Agents Chemother; 2016 Nov; 60(11):6635-6649. PubMed ID: 27572391 [TBL] [Abstract][Full Text] [Related]
17. Targeting Metabolism as a Novel Therapeutic Approach to Autoimmunity, Inflammation, and Transplantation. Bettencourt IA; Powell JD J Immunol; 2017 Feb; 198(3):999-1005. PubMed ID: 28115589 [TBL] [Abstract][Full Text] [Related]
18. PD-1/PD-L1 Pathway in Breast Cancer. Schütz F; Stefanovic S; Mayer L; von Au A; Domschke C; Sohn C Oncol Res Treat; 2017; 40(5):294-297. PubMed ID: 28346916 [TBL] [Abstract][Full Text] [Related]
19. Targeted therapy for thyroid cancer: An updated review of investigational agents. Deshpande HA; Gettinger SN; Sosa JA Curr Opin Investig Drugs; 2010 Jun; 11(6):661-8. PubMed ID: 20496261 [TBL] [Abstract][Full Text] [Related]